MINK THERAPEUTICS INC. - COMMON STOCK
0.9346
24-1月-25 15:45:00
15 分の遅延
株式
-0.0405
-4.15%
本日の幅
0.8835 - 0.9800
ISIN
N/A
ソース
NASDAQ
-
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
07 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
16 2 2023 08:28:43 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
11 1 2023 13:25:02 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
17 11 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
10 11 2022 08:05:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
03 11 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
20 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Host R&D Event November 10, 2022
05 10 2022 08:16:53 提供 Nasdaq GlobeNewswire
-
05 10 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at Upcoming Investor Conferences
31 8 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
09 8 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at BTIG Biotechnology Conference
02 8 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update
27 7 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
25 5 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report
10 5 2022 07:00:03 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update
27 4 2022 16:19:52 提供 Nasdaq GlobeNewswire
-
18 3 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update
03 3 2022 15:35:18 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
03 3 2022 08:28:47 提供 Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at Upcoming B. Riley Securities Virtual Oncology Conference
12 1 2022 08:41:30 提供 Nasdaq GlobeNewswire